PDE5A Antibodies

Santa Cruz Biotechnology delivers a wide array of PDE5A monoclonal antibodies for investigating phosphodiesterase 5A in various biological processes. PDE5A monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Phosphodiesterase 5A regulates intracellular levels of cyclic guanosine monophosphate (cGMP), playing a crucial role in vascular smooth muscle relaxation and blood flow regulation. PDE5A has emerged as a significant focus in cardiovascular research due to its involvement in various cardiovascular diseases and erectile dysfunction. Research into PDE5A continues to reveal new insights about its regulatory mechanisms and potential therapeutic applications. Understanding phosphodiesterase 5A function has become increasingly important for developing targeted treatments and improving clinical outcomes. Ongoing studies of PDE5A contribute to advancing our knowledge of cellular signaling pathways and their impact on human health. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of phosphodiesterase 5A and its role in human health and disease.